Up a level |
2016
Bazeos, Alexandra, Gower, Craig, Swann, Francine, Trask, Peter C., Dixon, Mark, Crompton, Noelle, Kinnersley, Nelson, Al-Sawaf, Othman, Goede, Valentin, Fingerle-Rowson, Gunter and Humphrey, Kathryn (2016). Progression By Lymphocytosis Correlates with Favourable Long-Term Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL). Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Estenfelder, Sven, Tausch, Eugen, Robrecht, Sandra, Bahlo, Jasmin, Goede, Valentin, Ritgen, Matthias, van Dongen, Jacques J. M., Langerak, Anton W., Fingerle-Rowson, Gunter, Kneba, Michael, Fischer, Kirsten, Hallek, Michael, Dohner, Hartmut and Stilgenbauer, Stephan (2016). Gene Mutations and Treatment Outcome in the Context of Chlorambucil (Clb) without or with the Addition of Rituximab (R) or Obinutuzumab (GA-101, G) - Results of an Extensive Analysis of the Phase III Study CLL11 of the German CLL Study Group. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Kovacs, Gabor, Robrecht, Sandra, Fink, Anna Maria, Bahlo, Jasmin, Cramer, Paula, von Tresckow, Julia, Maurer, Christian, Langerbeins, Petra, Fingerle-Rowson, Gunter, Ritgen, Matthias, Kneba, Michael, Doehner, Hartmut, Stilgenbauer, Stephan, Klapper, Wolfram, Wendtner, Clemens-Martin, Fischer, Kirsten, Hallek, Michael, Eichhorst, Barbara and Boettcher, Sebastian (2016). Minimal Residual Disease Assessment Improves Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia (CLL) Who Achieve Partial Response: Comprehensive Analysis of Two Phase III Studies of the German CLL Study Group. J. Clin. Oncol., 34 (31). S. 3758 - 3775. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
2015
Dimier, Natalie, Delmar, Paul, Ward, Carol, Morariu-Zamfir, Rodica, Fingerle-Rowson, Gunter, Bahlo, Jasmin, Fischer, Kirsten, Eichhorst, Barbara F., Goede, Valentin, van Dongen, Jacques J. M., Ritgen, Matthias, Boettcher, Sebastian, Langerak, Anton W., Kneba, Michael and Hallek, Michael (2015). A Model for Predicting Effect of Treatment on Progression-Free Survival Using Minimal Residual Disease As a Surrogate Endpoint in Chronic Lymphocytic Leukemia. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Goede, Valentin, Fischer, Kirsten, Bosch, Francesc ORCID: 0000-0001-9241-2886, Follows, George, Frederiksen, Henrik ORCID: 0000-0001-8905-0220, Cuneo, Antonio, Ludwig, Heinz, Crompton, Noelle, Maurer, Joerg, Uguen, Marianne, Fingerle-Rowson, Gunter and Hallek, Michael (2015). Updated Survival Analysis from the CLL11 Study: Obinutuzumab Versus Rituximab in Chemoimmunotherapy-Treated Patients with Chronic Lymphocytic Leukemia. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Gu, Ran, Santos, Leilani L., Ngo, Devi, Fan, HuaPeng, Singh, Preetinder P., Fingerle-Rowson, Gunter, Bucala, Richard, Xu, Jiake, Quinn, Julian M. W. and Morand, Eric F. (2015). Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis. Cytokine, 72 (2). S. 135 - 146. LONDON: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD. ISSN 1096-0023
Gu, Ran, Santos, Leilani L., Ngo, Devi, Fan, HuaPeng, Singh, Preetinder P., Fingerle-Rowson, Gunter, Bucala, Richard, Xu, Jiake, Quinn, Julian M. W. and Morand, Eric F. (2015). Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis. Cytokine, 72 (2). S. 135 - 146. LONDON: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD. ISSN 1096-0023
Mawhinney, Leona, Armstrong, Michelle E., O'Reilly, Ciaran, Bucala, Richard, Leng, Lin, Fingerle-Rowson, Gunter, Fayne, Darren, Keane, Michael P., Tynan, Aisling, Maher, Lewena, Cooke, Gordon ORCID: 0000-0003-0366-3603, Lloyd, David ORCID: 0000-0002-0824-9682, Conroy, Helen and Donnelly, Seamas C. (2015). Macrophage Migration Inhibitory Factor (MIF) Enzymatic Activity and Lung Cancer. Irish J. Med. Sci., 184. S. S523 - 1. LONDON: SPRINGER LONDON LTD. ISSN 1863-4362
2014
Freeman, Ciara Louise, Dixon, Mark, Houghton, Richard, Humphrey, Kathryn, Fingerle-Rowson, Gunter, Kreuzer, Karl-Anton, Engelke, Anja, Hallek, Michael and Goede, Valentin (2014). Risk Factors Associated with the Development of Infusion-Related Reactions in Patients with Chronic Lymphocytic Leukaemia Treated with Anti-CD20 Monoclonal Antibodies: Analysis of the CLL11 Study Dataset. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Freeman, Ciara Louise, Morschhauser, Franck, Sehn, Laurie H., Dixon, Mark, Houghton, Richard, Lamy, Thierry, Fingerle-Rowson, Gunter, Wassner-Fritsch, Elisabeth, Hallek, Michael, Salles, Gilles and Cartron, Guillaume (2014). Pattern of Cytokine Release in Patients with Chronic Lymphocytic Leukemia Treated with Obinutuzumab and Possible Relationship with Development of Infusion Related Reactions (IRR). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Mawhinney, Leona, Armstrong, Michelle E. ORCID: 0000-0001-7729-755X, O'Reilly, Ciaran ORCID: 0000-0001-8926-1853, Bucala, Richard, Leng, Lin ORCID: 0000-0002-0605-358X, Fingerle-Rowson, Gunter, Fayne, Darren ORCID: 0000-0003-2417-5406, Keane, Michael P., Tynan, Aisling ORCID: 0000-0002-6856-2259, Maher, Lewena, Cooke, Gordon ORCID: 0000-0003-0366-3603, Lloyd, David ORCID: 0000-0003-0658-8995, Conroy, Helen ORCID: 0000-0002-5857-2760 and Donnelly, Seamas C. (2014). Macrophage Migration Inhibitory Factor (MIF) Enzymatic Activity and Lung Cancer. Mol. Med., 20. S. 729 - 736. MANHASSET: FEINSTEIN INST MED RES. ISSN 1528-3658
2012
Stilgenbauer, Stephan, Busch, Raymonde, Schnaiter, Andrea, Paschka, Peter, Rossi, Marianna, Doehner, Konstanze, Zenz, Thorsten, Buehler, Andreas, Winkler, Dirk, Edelmann, Jennifer, Mertens, Daniel, Bullinger, Lars, Kless, Sabrina, Mack, Silja, Boettcher, Sebastian, Ritgen, Matthias, Kneba, Michael, Jaeger, Ulrich, Lichter, Peter, Patten, Nancy, Wenger, Michael K., Mendila, Myriam, Fingerle-Rowson, Gunter, Cazzola, Mario, Wendtner, Clemens, Fink, Anna Maria, Fischer, Kirsten, Hallek, Michael and Doehner, Hartmut (2012). Gene Mutations and Treatment Outcome in Chronic Lymphocytic Leukemia: Results From the CLL8 Trial. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971